Evidence map›Paper›PMID 37110217›Full record

ArticleMetabolites2023

Quality Control of Targeted Plasma Lipids in a Large-Scale Cohort Study Using Liquid Chromatography-Tandem Mass Spectrometry.

Akiyoshi Hirayama, Takamasa Ishikawa, Haruka Takahashi, Sanae Yamanaka, Satsuki Ikeda, Aya Hirata, Sei Harada, Masahiro Sugimoto, Tomoyoshi Soga, Masaru Tomita and 1 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Akiyoshi HirayamaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.ORCID 0000-0002-0440-6820
Takamasa IshikawaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Haruka TakahashiInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Sanae YamanakaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Satsuki IkedaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Aya HirataDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, Shinjuku 160-8582, Tokyo, Japan.ORCID 0000-0003-1439-4242
Sei HaradaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Masahiro SugimotoInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.ORCID 0000-0003-3316-2543
Tomoyoshi SogaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.ORCID 0000-0001-9502-2509
Masaru TomitaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Toru TakebayashiInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan.
Keio University · JPTokyo Medical University · JP

Funding

Japan Agency for Medical Research and Development JP18km0405209Japan Science and Technology Agency JPMJOP1842Japan Society for the Promotion of Science JP20H05743
6 · The paper itself

Abstract

High-throughput metabolomics has enabled the development of large-scale cohort studies. Long-term studies require multiple batch-based measurements, which require sophisticated quality control (QC) to eliminate unexpected bias to obtain biologically meaningful quantified metabolomic profiles. Liquid chromatography-mass spectrometry was used to analyze 10,833 samples in 279 batch measurements. The quantified profile included 147 lipids including acylcarnitine, fatty acids, glucosylceramide, lactosylceramide, lysophosphatidic acid, and progesterone. Each batch included 40 samples, and 5 QC samples were measured for 10 samples of each. The quantified data from the QC samples were used to normalize the quantified profiles of the sample data. The intra- and inter-batch median coefficients of variation (CV) among the 147 lipids were 44.3% and 20.8%, respectively. After normalization, the CV values decreased by 42.0% and 14.7%, respectively. The effect of this normalization on the subsequent analyses was also evaluated. The demonstrated analyses will contribute to obtaining unbiased, quantified data for large-scale metabolomics.

Indexed as

cohort studylipidliquid chromatography–mass spectrometryquality controltargeted lipidomics

Identifiers

PMID37110217
PMCPMC10146188
OpenAlexW4365514180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.